ACTINIUM PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.00 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-08-14
- ACTINIUM PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $1.00M, a 135.53% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-03-31 was $993.00K, a 135.87% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-09-30 was $970.00K, a 135.44% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-06-30 was $425.00K, a 7.41% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $2.79M, a 64.99% increase from fiscal 2021.
- ACTINIUM PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $1.69M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.00M 10-Q · filed 2023-08-14 | $1.99M derived: sum of 2 quarters · filed 2023-08-14 | ||
| 2023-03-31 | $993.00K 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | $2.79M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $970.00K 10-Q · filed 2022-11-14 | $1.40M derived: sum of 2 quarters · filed 2023-08-14 | $1.82M derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-06-30 | $425.00K 10-Q · filed 2023-08-14 | $846.00K derived: sum of 2 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $421.00K 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $1.69M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $412.00K 10-Q · filed 2022-11-14 | $871.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.25M derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | $459.00K 10-Q · filed 2022-11-14 | $835.00K derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2021-03-31 | $376.00K 10-Q · filed 2022-11-14 | |||
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-12 | $6.00K derived: sum of 2 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $4.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |